Effect of brimonidine tartrate gel 0.33% versus tretinoin cream 0.05% on post-acne erythema
Phase 3
Recruiting
- Conditions
- Acne.Acne
- Registration Number
- IRCT20120215009014N490
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Age 18 to 70 years
Erythema after acne
Exclusion Criteria
Pregnancy or breastfeeding
Taking anti-acne drugs in the last 3 months
Contraindications to Brimonirin (including treatment failure, brain failure, depression, blood pressure, scleroderma, Sjogren's syndrome, Raynaud's phenomenon)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of post-acne erythema. Timepoint: Before the intervention and in the fourth and eighth weeks after the intervention. Method of measurement: By clinical examination.
- Secondary Outcome Measures
Name Time Method Skin burning. Timepoint: In the fourth and eighth weeks after the intervention. Method of measurement: By taking a history.